This article summarises the guidance on the assessment of drug dependence from the drug misuse and dependence guidelines jointly produced by the Department of Health, the Scottish Government, the Welsh Assembly Government and the Northern Ireland Executive. The guidelines were last updated in September 2007.¹ It should be read in conjunction with the separate overview article Drug Misuse and Dependence: UK Guidelines.

Introduction

• Good assessment of a drug misuser requires training and competency in the clinician.
• An empathic, non-judgmental approach should be used.
• The full assessment process may take several consultations. A drug-misusing patient may present at a time of crisis. An exhaustive initial interview may reduce the chance of them engaging in a treatment programme. However, enough information needs to be obtained in the initial consultation to assess the presenting problems safely.
• Relatives or carers should be involved where appropriate.
• A multidisciplinary approach to assessment may be needed as the drug misuser may have associated physical and psychological health problems, social functioning problems (including housing and employment) and/or be involved with the criminal justice system.
• A written document should be produced that can be used as the basis for discussing care planning, goals and objectives with the patient.
• There may be a locally agreed shared assessment process/care pathway already in place.
• Once a full assessment has been carried out, a care or treatment plan can be established.

Aims of assessment

• Treating any emergency problem.
• Confirming the patient is taking drugs (history, examination, drug testing).
• Assessing the degree of dependence.
• Identifying physical and mental health problems.
• Identifying social problems: housing, employment, domestic violence, offending.
• Assessing risk behaviour.
• Determining expectations of treatment and desire to change.
• Determining the need for substitute medication.
• Assessing competency of young people to consent to treatment and involving those with parental responsibility as appropriate.
• Assessing any risk to dependent children of drug-misusing parents.
• In private practice, ensuring the patient is able to pay for treatment by legitimate means.
• Providing access to sterile injecting equipment and safe needle disposal as needed.
• Providing testing for hepatitis and HIV.
• Providing immunisation against hepatitis B.
• Determining the most appropriate level of expertise to manage the patient. Referral or liaison with specialist services may be needed.
• Notification of the patient to the relevant national drug monitoring system.

Assessment of current drug and alcohol use

History

This should include:

• Types of drugs used.
• Quantity, frequency and pattern of use.
• Route of administration.
• Symptoms of dependence.
• Source of drug (including preparation).
• Prescribed medication.
• Tobacco use.
• Alcohol use, including quantity, frequency and pattern of use.
• Alcohol dependence symptoms.

Drug testing

• Staff performing drug testing should be competent in taking samples and, if appropriate, in reading results. Laboratory testing must be done in accredited laboratories.
• Screening tests: these are usually carried out first. They are quick, cheap and easy. They are usually done using immunoassay and can be done in the laboratory or using point of care or dipstick tests. Negative results can be reliably accepted. Positive results usually need confirmation using a confirmatory test.
• Confirmatory tests: these tend to use gas or liquid chromatography and mass spectrometry. They are slower and more expensive but drugs and their metabolites can be detected. It is the gold standard for drug testing.
• Urine testing: this is what is usually performed. It can show drug use over recent days and is a noninvasive test. Urine specimens may be adulterated (e.g. addition of chemicals, dilution by drinking large volumes of fluid), substituted, or be prone to pre-collection abstinence of drugs that may produce a misleading result. It is only very occasionally necessary to directly observe a urine specimen being given, and the patient's informed consent is needed for this.
• Oral fluid testing: oral fluid is easier to collect but drugs are present in lower concentrations and only very recent drug use over the last 24-48 hours can be detected. However, it is less easy to adulterate.
• Hair testing: this can show drug use over the past few months. It is poor at detecting very recent use. However, it does not differentiate between continual and sporadic use. It is also more complicated and is only performed in some laboratories.
• Random intermittent drug screening is likely to be the most practical and cost-effective way to provide reliable information about a person's recent drug use.
• Written procedures should be in place for the collection and storage of biological samples, their dispatch to a laboratory and the discussion and management of reported results.

Assessment of risk

Risk assessment should be carried out looking at:

• Overdose risk.
• Polydrug and alcohol misuse.
• Unsafe injecting practices.
• Unsafe sexual practices.
• Any risks of self-harm or harm to others.
• Any risks to dependent children.
  • Ask about children, ages and level of contact.
  • What is the effect of the drug use on the parent's functioning?
  • What is the effect of drug-seeking behaviour on the children - are they left unsupervised, or have contact with unsuitable characters?
  • How is drug use funded - diversion of family income?
  • Does the parent's physical/mental health affect their parenting?
  • Can they provide emotional support to the children?
  • Effect on family routines, e.g. getting to school on time?
  • Are there other support networks - family, friends?
  • Are the drugs and paraphernalia being stored safely?
  • Are the parents able to access professional help?

Local child protection procedures should be followed if there is risk of significant harm to children. Advice should be given about access to clean injecting equipment and needle exchanges. Information should be given about reducing the risk of overdose and contracting blood-borne infections.

Assessment of social functioning

Issues covered should include:

• Partners, family and support.
• Housing.
• Education.
• Employment.
• Domestic violence.
• Benefits and financial problems.
• Childcare issues: pregnancy, parenting, child protection.

Assessment of criminal involvement and offending

Questions should be asked around:

• Arrests, outstanding warrants and charges.
• Probation.
• Imprisonment.
• Violent offences and criminal activity.
• Fines.
• Involvement with workers in the criminal justice system, e.g. probation officers.

Assessment of physical and psychological health

It may not always be the GP to whom the patient first presents. Therefore, the clinician involved should perform a health assessment within their competency and refer to other services as appropriate.

History

History taking should cover the following:

• Presenting symptoms and perceptions as to why this consultation is taking place.
• Past medical history.
• Psychiatric history and any current symptoms.
• Drug-related complications: abscesses, venous thromboses, septicaemia, endocarditis, constipation.
• History of accidental/deliberate overdose.
• Current or past infection with blood-borne viruses.
• Cervical screening, menstrual and pregnancy history in women.
• Sexual health and sexually transmitted infection history and contraceptive use.
• Oral health.
• Current prescribed and non-prescribed medication.
• Allergies and sensitivities.

Examination

This should include:

• Assessment of mental health.
• Assessment of injection sites if injecting/injected in the past: limbs, groins, etc.
• Weight and height measurement.
• Urine testing for diabetes and infection.
• Blood pressure measurement.
• General assessment of respiratory, cardiovascular and other systems depending on history/presenting symptoms.

Investigations

A number of investigations may be appropriate depending on the history, risks, symptoms and physical signs:

• Testing for hepatitis B and C (including polymerase chain reaction (PCR) for hepatitis C virus RNA).
• Testing for HIV.
• Pregnancy testing.
• Blood tests to assess liver, thyroid and renal function and haematological indices.
• ECG.
• Further investigation of cardiovascular, gastrointestinal and respiratory systems as appropriate.

Other considerations

There is also the potential for health promotion measures including:

• Immunisations for hepatitis B (and possibly hepatitis A).
• Cervical cancer screening.
• Safer sex and contraceptive advice.
• Diet and nutritional advice.

Document references

1. Drug Misuse and Dependence - UK Guidelines on Clinical Management, Dept of Health (September 2007)

Acknowledgements